EAS 2017 Congress Prague highlights
Language English Country Ireland Media print-electronic
Document type Congress
Persistent link
https://www.medvik.cz/link/pmid28666532
PubMed
28666532
DOI
10.1016/j.atherosclerosis.2017.06.021
PII: S0021-9150(17)30270-8
Knihovny.cz E-resources
- Keywords
- Congress, EAS Consensus Panel, EAS FH studies collaboration, Highlights, LDL causes ASCVD, Managing triglycerides, Novel genetic insights, PCSK9 inhibition, Prague,
- MeSH
- Atherosclerosis prevention & control therapy MeSH
- Hypercholesterolemia therapy MeSH
- Immune System MeSH
- Cardiology methods trends MeSH
- Cardiovascular Diseases blood prevention & control MeSH
- Humans MeSH
- PCSK9 Inhibitors MeSH
- Societies, Medical MeSH
- Triglycerides blood MeSH
- Research Design MeSH
- Check Tag
- Humans MeSH
- Publication type
- Congress MeSH
- Geographicals
- Czech Republic MeSH
- Names of Substances
- PCSK9 Inhibitors MeSH
- PCSK9 protein, human MeSH Browser
- Triglycerides MeSH
References provided by Crossref.org
